Bio Screening Industry News

Westborough, MA, October 17, 2005 – The BioProcess International™ Asia-Pacific conference
and exhibition to be held in Singapore next month will address the needs of Asian, American, and
European executives and scientists who are looking for global alliance and technological
innovations, as well as best practices to improve their bioprocessing techniques and benchmark
their manufacturing capabilities and skills. The event will be held from November 7-9, 2005 at The
Shangri-La Hotel in Singapore.

“Many operations in the development of biopharmaceuticals have moved to Asia” said Scott M.
Wheelwright, Ph.D., President, Strategic Manufacturing Worldwide Inc., USA; and a member of
the event’s Scientific Advisory Board. “Even with lower efficiencies, a company can lower its labor
costs by a factor of three by moving operations to a lesser-developed country. And the lower labor
rates translate into lower capital costs because the expense of facility construction and
equipment contains a significant labor component.”

In his article published in the October issue of the premier BioProcess International™ magazine,
Scott further elaborates that in China, the production of biopharmaceuticals has grown at a rate of
5-10% over the past few years and is expected to continue to expand at about 10% per year;
while in India, one observer estimates the industry has been growing at 25% for the past three
years and expects to double from the current $800 million over the next three years.

Whether you’re in upstream or downstream processing, whether you’re a business development
executive or the head of bioprocessing and manufacturing, you don’t want to miss this opportunity
to:

Find out how you can reduce your capital and labor costs
Meet potential collaborators, find out who’s who and understand the market landscape of
the biopharmaceutical industry in Asia
Hear about the scientific and regulatory challenges of biologics in Asia
Benchmark and scale up your production processes with efficiency and quality
Gain best practices in upstream and downstream process development and apply them
to your production needs
These and many more exciting topics will be addressed at the BioProcess International™ Asia
Pacific conference and exhibition in Singapore. Carefully researched with scientific advisors, this
event is meant to enable executives and scientists from all over the world to come together to
learn about opportunities for business collaborations and share insights into scientific advances.
This is your chance to make and leave your mark in the Asia-Pacific biopharmaceutical industry.

For detailed information about the event, and to register online, visit:
http://www.IBCLifeSciences.com/BPI/Asia